GEODE CAPITAL MANAGEMENT, LLC
Position in ELDN — Eledon Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in ELDN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,709,007
+$2,190,317 QoQ
Shares Held
1,956,601
+9.2% QoQ
Ownership
2.41%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 159 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. ELDN ranks #210 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ELDN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,709,007 | 1,956,601 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $5,518,690 | 1,791,783 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,146,641 | 1,421,617 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $3,545,553 | 1,368,940 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,750,477 | 1,383,940 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,260,170 | 666,717 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,731,975 | 663,101 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $941,364 | 378,058 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $909,450 | 344,489 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $372,656 | 180,901 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $316,870 | 176,039 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $241,173 | 176,039 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $232,420 | 169,650 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $304,796 | 129,151 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $294,464 | 129,151 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $357,323 | 129,465 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $314,237 | 128,786 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $499,237 | 126,710 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $558,791 | 126,710 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $788,308 | 127,558 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $985,696 | 124,614 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,060,616 | 99,123 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||